| |
| |
|
| Insider
Information: |
Cantley Lewis Clayton Jr. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,475 |
|
|
Indirect Shares
|
121,121 |
|
|
| Direct
Value |
$2,729,172 |
|
|
|
Indirect Value
|
$4,159,295 |
|
|
| Total
Shares |
200,596 |
|
|
| Total
Value |
$6,888,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Director |
2017-12-07 |
79,475 |
2017-12-07 |
121,121 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • • |
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
363,636 |
|
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
181,818 |
181,818 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-12-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
181,818 |
181,818 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-03-29 |
4 |
AS |
$36.28 |
$22,748 |
D/D |
(627) |
129,683 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-03-29 |
4 |
AS |
$36.28 |
$22,675 |
I/I |
(625) |
129,693 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-30 |
4 |
AS |
$36.81 |
$23,080 |
D/D |
(627) |
110,286 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-30 |
4 |
AS |
$36.81 |
$23,006 |
I/I |
(625) |
110,318 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-02-25 |
4 |
AS |
$36.90 |
$23,136 |
D/D |
(627) |
131,086 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-02-25 |
4 |
AS |
$36.90 |
$23,063 |
I/I |
(625) |
131,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-29 |
4 |
AS |
$37.81 |
$23,707 |
D/D |
(627) |
110,913 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-29 |
4 |
AS |
$37.81 |
$23,631 |
I/I |
(625) |
110,943 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-03-30 |
4 |
AS |
$38.09 |
$23,806 |
I/I |
(625) |
129,068 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-03-30 |
4 |
AS |
$38.09 |
$23,882 |
D/D |
(627) |
129,056 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-02-26 |
4 |
AS |
$38.89 |
$24,384 |
D/D |
(627) |
130,459 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-02-26 |
4 |
AS |
$38.89 |
$24,306 |
I/I |
(625) |
130,465 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-06-27 |
4 |
AS |
$40.37 |
$25,312 |
D/D |
(627) |
125,921 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-06-27 |
4 |
AS |
$40.37 |
$25,231 |
I/I |
(625) |
125,943 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-01-29 |
4 |
AS |
$41.52 |
$25,950 |
I/I |
(625) |
131,715 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-01-29 |
4 |
AS |
$41.52 |
$26,033 |
D/D |
(627) |
131,713 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-07-25 |
4 |
AS |
$41.85 |
$26,156 |
I/I |
(625) |
112,193 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-07-25 |
4 |
AS |
$41.85 |
$26,240 |
D/D |
(627) |
112,167 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-06-28 |
4 |
AS |
$43.38 |
$27,199 |
D/D |
(627) |
125,294 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-06-28 |
4 |
AS |
$43.38 |
$27,113 |
I/I |
(625) |
125,318 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-07-26 |
4 |
AS |
$43.74 |
$27,338 |
I/I |
(625) |
111,568 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-07-26 |
4 |
AS |
$43.74 |
$27,425 |
D/D |
(627) |
111,540 |
0 |
- |
|
127 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
